Public Health +

McMaster Plus Public Health + est offert par l’entremise de la McMaster Health Knowledge Refinery. Chaque article extrait de plus de 120 revues médicales et paramédicales universitaires est soumis à un examen critique afin que sa rigueur méthodologique soit jugée. Les articles retenus sont cotés (maximum 7) par des cliniciens quant à leur pertinence et leur intérêt, et sont affichés sur ce site. Les articles sont mis à jour chaque semaine et sont interrogeables à partir d’une liste d’archives.

Afin d'en savoir plus sur le processus, allez à McMaster PLUS. Pour vous inscrire comme évaluateur (afin de pouvoir limiter votre choix aux articles de grande qualité qui correspondent à votre champ d’intérêt, p. ex. les maladies transmissibles), cliquez ici.

Détails de l’article

Téléchargez le sommaire en PDF

Titre: Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis.
Auteurs: Minion J, Leung E, Talbot E
Source: Eur Respir J. 2011 Dec;38(6):1398-405. Epub 2011 Jun 23.
Cote de pertinence: 6
Cote d'intérêt: 5
Extrait:

Lipoarabinomannan (LAM) is a potential marker of active tuberculosis (TB). We performed a systematic review and meta-analysis regarding use of urinary LAM assays for diagnosing active TB. We systematically searched for published and unpublished studies that evaluated urinary LAM for active TB diagnosis. Extracted data were pooled using bivariate random effects models and hierarchical summary receiver operating characteristic curves. Heterogeneity was explored through subgroup analysis and meta-regression. Quality was assessed according to standardised QUADAS (Quality Assessment of Diagnostic Accuracy Studies) criteria. In seven studies that assessed test accuracy in microbiologically confirmed cases only, estimates of sensitivity ranged from 13% to 93%, while specificity ranged from 87% to 99%. In five studies that assessed accuracy in clinical and confirmed TB cases, sensitivity ranged from 8% to 80%, while specificity ranged from 88% to 99%. In five studies with results stratified by HIV status, sensitivity was 3-53% higher in HIV-positive than HIV-negative subgroups; sensitivity was highest with advanced immunosuppression. The LAM urinary assay has several characteristics that make it attractive for diagnosing active TB, but has suboptimal sensitivity for routine clinical use. Further studies are needed to evaluate the potential value of the LAM assay in individuals with advanced HIV or for diagnosis of paediatric TB.

The full text may be available from PubMed.